Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist
Clinical trial NCT00960752 · COMPLETED
Trial details
- NCT number
- NCT00960752
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-20
- Primary completion
- 2020-07-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.